Evaluation of the Effects of Hesperidin and Flaxseed Supplementation in Patients With Prediabetes
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- prediabetes
研究概览
简要总结
To study the effects of Hesperidin and flaxseed supplement in patients with prediabetes, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin and 30 gram flaxseed for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age of 18 to 70 years prediabetes: impaired fasting glucose (>100 mg/dL) and/or HbA1C 5.7% to 6.5%, and overweight or obese with body mass index range of 25 to 40 kg/m2
排除标准
- •pregnancy or lactation
- •A history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease; Cirrhosis
- •Following program to lose weight in recent 3 mo
研究组 & 干预措施
hesperidin and flaxseed
干预措施: hesperidin and flaxseed (Dietary Supplement)
control
干预措施: control (Other)
结局指标
主要结局
prediabetes
时间窗: 12 weeks
number of participants with normal plasma glucose
次要结局
未报告次要终点
研究者
Dr Azita Hekmatdoost
Principal Investigator
National Nutrition and Food Technology Institute
